DrugPatentWatch Database Preview

Flutemetamol f-18 - Generic Drug Details

« Back to Dashboard

What are the generic sources for flutemetamol f-18 and what is the scope of flutemetamol f-18 patent protection?

Flutemetamol f-18 is the generic ingredient in one branded drug marketed by Ge Healthcare and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Flutemetamol f-18 has seventy-six patent family members in twenty-three countries.

One supplier is listed for this compound.

Summary for flutemetamol f-18

International Patents:	76
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	1
Suppliers / Packagers:	1
Bulk Api Vendors:	1
Clinical Trials:	18
Patent Applications:	14
DailyMed Link:	flutemetamol f-18 at DailyMed

Pharmacology for flutemetamol f-18

Drug Class	Radioactive Diagnostic Agent
Mechanism of Action	Radiopharmaceutical Activity

Synonyms for flutemetamol f-18

((18 sup)F)AH110690

[18F]-Flutemetamol

[18F]-Flutemetamol F18

[18F]AH110690

[18F]flutemetamol

18F-Flutemetamol

2-(3-((18 sup)F)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol

2-(3-(sup 18)f)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol

2-[3-((18)F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol

2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol

6-Benzothiazolol, 2-(3-(fluoro-(sup 18)F)-4-(methylamino)phenyl)-

765922-62-1

CHEBI:76611

CHEMBL2042122

D10231

DB09151

DTXSID80227394

Flutemetamol

flutemetamol ((18)F)

Flutemetamol ((sup 18)F)

Flutemetamol ((sup18)F)

flutemetamol (18F)

Flutemetamol (18F) [INN]

Flutemetamol F 18

Flutemetamol F 18 (USAN)

Flutemetamol F 18 [USAN]

flutemetamol F 18 injection

Flutemetamol F18

GTPL7342

L49M066S0O

SCHEMBL10032147

UNII-L49M066S0O

Vizamyl

Vizamyl (TN)

US Patents and Regulatory Information for flutemetamol f-18

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-002	Oct 25, 2013		RX	Yes	Yes
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-001	Oct 25, 2013		DISCN	Yes	No			Y	Y
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-001	Oct 25, 2013		DISCN	Yes	No			Y	Y
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-002	Oct 25, 2013		RX	Yes	Yes			Y	Y
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-001	Oct 25, 2013		DISCN	Yes	No
Ge Healthcare	VIZAMYL	flutemetamol f-18	INJECTABLE;INTRAVENOUS	203137-001	Oct 25, 2013		DISCN	Yes	No			Y

International Patents for flutemetamol f-18

Country	Document Number	Estimated Expiration
Norway	330861
China	101790387
Denmark	1334091
Spain	2393921
Norway	2015005
World Intellectual Property Organization (WIPO)	2004083195

Supplementary Protection Certificates for flutemetamol f-18

Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2015	Austria		PRODUCT NAME: (18F) - FLUTEMETAMOL; REGISTRATION NO/DATE: EU/1/14/941 (MITTEILUNG) 20140826
2015000017	Germany		PRODUCT NAME: FLUTEMETAMOL (18F) IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/14/941 20140822
3 5003-2015	Slovakia		PRODUCT NAME: FLUTEMETAMOL (18F); REGISTRATION NO/DATE: EU/1/14/941 20140822
2015 00008	Denmark		PRODUCT NAME: RADIOAKTIVE ISOTOPER AF FLUTEMETAMOL, SAERLIGT FLUTEMETAMOL (18F); REG. NO/DATE: EU/1/14/941 20140822
C0005	France		PRODUCT NAME: FLUTEMETAMOL (18 F); REGISTRATION NO/DATE: EU/1/14/941 20140822
15006	Norway		PRODUCT NAME: VIZAMYL; REG. NO/DATE: EU/1/14/941 20140822